CONMED Corporation

NYQ: CNMD
Live Quote

📈 ZcoreAI Score

Our AI model analyzes CONMED Corporation's price action across multiple timeframes using regression channels and statistical scoring.

Get CNMD Z-Score →

About CONMED Corporation

Healthcare Medical Devices
CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries. It also provides battery-powered, autoclavable, large, and small bone power tool systems for use in orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries under the Hall surgical brand name. In addition, the company offers general surgery products, such as clinical insufflation systems under the AirSeal brand; smoke removal devices under the Buffalo Filter brand; endomechanical products, including the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, used in minimally invasive surgeries; and electrosurgical solution comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. Further, it provides endoscopic technologies, including therapeutic and diagnostic products for use in gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, infection prevention, and patient monitoring include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. It markets its products directly to hospitals, surgery centers, and other healthcare institutions, as well as through medical specialty distributors. The company was incorporated in 1970 and is headquartered in Largo, Florida.

📊 Fundamental Analysis

CONMED Corporation demonstrates a profit margin of 3.4%, which is below the sector average, suggesting competitive pressure.

The company recently reported 7.9% revenue growth, which is modest compared to its industry peers.

Return on Equity (ROE) is 4.7%, which suggests room for improvement in capital utilization.

At a current price of $36.74, CNMD currently trades near the bottom of its 52-week range (13%), indicating potential value or weakness (Range: $33.21 - $61.08).

💰 Valuation Insight

CNMD is valued broadly in line with the sector at a PE of 24.33. Analysts expect earnings growth, as indicated by a lower forward PE.

🏥 Financial Health

🔴 Profit Margin Weak
🔴 Debt/Equity Elevated
🔴 Revenue Growth Weak
🔴 Return on Equity Weak
⚠️ Beta (Risk) Moderate Volatility

Key Financials

Market Cap
$1.13B
Trailing P/E
24.33
Forward P/E
7.46
Beta (5Y)
0.99
52W High
$61.08
52W Low
$33.21
Avg Volume
517K
Day High
Day Low
Get CNMD Z-Score on Dashboard 🚀